Skip to main content
Caplight Logo









Evvy

Evvy

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.evvy.com/

Last Round

Series A

Sep 27, 2023

Total Funding Raised

$19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Evvy is a healthtech company that provides an at-home testing platform to analyze the vaginal microbiome and deliver personalized health insights and care plans.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Precision Medicine, Subscription Commerce

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

vaginal microbiome testat-home diagnosticfemtechmetagenomic sequencingvaginal healthprobiotic supplementpersonalized care planDTC healthhealth coachingmicrobiome analysisbacterial vaginosis testsubscription healthprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evvy Comparables

Compare Evvy with similar companies based on industry and business-model similarity.

Evvy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Juno Bio
84%
Ombre
81%
Daye
77%

Evvy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 27, 2023
SeedJul 14, 2021

Key People

Founding team and executive leadership

Pita Navarro

Co-Founder, Chief Scientific Officer

Founding Team

Priyanka Jain

Co-Founder CEO

Founding Team

Kwame Thomison

Chief Technology Officer

Executive Team

Evvy Investors

Notable investors and investment history

Evvy investors
InvestorRounds
Human VenturesSeed
BBG VenturesSeed
General CatalystSeries A, Seed
BoxGroupSeed
Left Lane CapitalSeries A
Amboy Street VenturesSeries A
VirtueSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 28, 2026

    Recognized by The Webby Awards.

  • Jan 28, 2026

    Recognized by Fast Company on three distinct lists.

Evvy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evvy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evvy's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range61
Year Founded2020
Last FundingSep 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?